{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 3089"}, "official-title": {"#tail": "\n\t", "#text": "To amend section 503A of the Federal Food, Drug, and\n\t\t  Cosmetic Act with respect to pharmacy compounding."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130912", "#text": "September 12, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Griffith of\n\t\t\t Virginia", "@name-id": "G000568"}, "cosponsor": [{"#tail": ", and ", "#text": "Ms.\n\t\t\t DeGette", "@name-id": "D000197"}, {"#tail": ") introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Mr. Gene Green of\n\t\t\t Texas", "@name-id": "G000410"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H55533685867648E38240CEDB6C47E824", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Compounding Clarity Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H7B654A7D60D2494D9F040DA3F3F8BA1C"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 503A of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 353a", "@value": "usc/21/353a"}, "@parsable-cite": "usc/21/353a", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "\n\t\t\t Traditional pharmacy compounding"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "503A."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Traditional\n\t\t\t\tpharmacy compounding"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "Sections 501(a)(2)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:501/ss:a/p:2/sp:B"}, {"#tail": ", and ", "@entity-type": "act", "#text": "502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": " and\n\t\t\t\t", "@entity-type": "act", "#text": "505 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " shall not apply to a\n\t\t\t\t", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "\n              ", "italic": {"#tail": "drug product for human use if each of the following conditions\n\t\t\t\tis met:"}}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t\tGeneral"}, "paragraph": [{"#tail": "\n            ", "@id": "H70EE068232C54639B5A4C83926874EEB", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Identified\n\t\t\t\tpatient and receipt of prescription"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The drug product is compounded in\n\t\t\t\taccordance with one of the following:", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The drug product is\n\t\t\t\tcompounded by a licensed pharmacist in a State-licensed pharmacy or a Federal\n\t\t\t\tfacility, or by a licensed physician, for an identified individual patient\n\t\t\t\tbased on the receipt of a valid prescription.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "HF1D5A74C8758475EBC1496D591058A60"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "historical demand\n\t\t\t\tfor the drug product; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H91AD963F125C4901B6D2D3A4739E173A", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a\n\t\t\t\thistory of prescriptions for the drug product generated solely within an\n\t\t\t\testablished relationship between the licensed pharmacist or licensed physician\n\t\t\t\twho is performing the compounding and\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the individual\n\t\t\t\tpatient; or"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "H3FA354519C374145A7EA7D58FF10723A", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the physician or\n\t\t\t\tother licensed practitioner who writes the prescription."}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H53856E85EE8340EDBEF284B598D23B27", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H82AEFF522A784499B18F99B719C3FE75"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Anticipatory\n\t\t\t\tcompounding"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The drug product\n\t\t\t\tis compounded by a licensed pharmacist in a State-licensed pharmacy or a\n\t\t\t\tFederal facility, or by a licensed physician, in limited quantities before the\n\t\t\t\treceipt of a valid prescription for an identified individual patient, based\n\t\t\t\ton\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                ", "@id": "H3B4D146C45424C18B46DB01E8A107918"}, {"continuation-text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " because\n\t\t\t\tof the failure of a pharmacist or a physician to account for valid\n\t\t\t\tpatient-specific prescriptions or valid patient names as required by such\n\t\t\t\tclause, so long as the pharmacist or physician makes a good faith, reasonable\n\t\t\t\teffort to account for the prescriptions or names, as applicable, and does not\n\t\t\t\tcontinue to compound drug products under this subparagraph for a health care\n\t\t\t\tpractitioner or facility with a history of failing to submit such prescriptions\n\t\t\t\tor patient names.", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:B/cl:ii", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "Compounding under this\n\t\t\t\tsubparagraph shall not be considered to be in violation of "}, "#tail": "\n            ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the drug product\n\t\t\t\twill be administered by a health care practitioner within a physician\u2019s office,\n\t\t\t\ta hospital, or another health care setting;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H551DD76698D04184A99C47AD005D5BF3", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "valid\n\t\t\t\tpatient-specific prescriptions or, when a compounded drug product is\n\t\t\t\tadministered within the same health system in which it was compounded, valid\n\t\t\t\tpatient names\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "are submitted,\n\t\t\t\telectronically or otherwise, to the pharmacist or physician who performs the\n\t\t\t\tcom\u00adpound\u00ading, not later than 7 business days after the drug product is\n\t\t\t\tadministered; and"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "H145D328A4FC34B9DBBD4FBBBEEEC4C00", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "will, in the\n\t\t\t\taggregate, account for the total volume of drug product compounded pursuant to\n\t\t\t\tthe non-patient-specific purchase order;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H965178251B50454FA71FA3B46D68FA60", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H3FC96FDD95D346B8A067373091F44CE8"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "during any 6-month period, of the total\n\t\t\t\tdrug products dispensed from the facility at which the drug product was\n\t\t\t\tcompounded, not more than 5 percent are compounded sterile drug products that\n\t\t\t\tare\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "dispensed pursuant\n\t\t\t\tto this subparagraph; and"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "HF7D4C0A12D764F039726C643F8769A1B", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shipped\n\t\t\t\tinterstate;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "HBE27C64B2BFE49BD80674A247E861AC2", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H0D2E2863DADE4CFCB1B4D35F7545F2A9"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "records of the\n\t\t\t\tcompounding will be kept for not less than 3 years; and"}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "H62EE1CBB4E64448A92F649E94643A0CB", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": [{"#tail": " and the statement ", "#text": "Office Use Only"}, {"#tail": "\n\t\t\t\tappear on the compounded drug product.", "#text": "Not for resale"}], "#text": "the statement\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "H428D527521CB4F61BB4D99D0CBC16917", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Compounding for\n\t\t\t\toffice use"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The drug product\n\t\t\t\tis compounded by a licensed pharmacist in a State-licensed pharmacy or a\n\t\t\t\tFederal facility, or by a licensed physician, pursuant to a\n\t\t\t\tnon-patient-specific purchase order and\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                ", "@id": "H194F7C5E33EC4B88955CA9166761DE7F"}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:A", "@proposed": "true"}, {"#tail": ", or ", "@entity-type": "act", "#text": "(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": ", the drug product is\n\t\t\t\tcompounded, stored, and dated in compliance with the United States\n\t\t\t\tPharmacopoeia chapters that are applicable to pharmaceutical compounding\n\t\t\t\t(including the chapter on sterile preparations).", "@entity-type": "act", "#text": "(C) of paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:C", "@proposed": "true"}], "#text": "Irrespective of whether a drug product is compounded\n\t\t\t\tunder "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Quality\n\t\t\t\tstandards"}, "#text": "\n              ", "@id": "HC2547B71AF7D48968C15E62722715775"}, {"#tail": "\n            ", "@id": "HA004360A49044345BB46A1E6527242EC", "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Bulk drug\n\t\t\t\tsubstances"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " published at section\n\t\t\t\t207.3(a)(4) of title 21 of the Code of Federal Regulations (or any successor\n\t\t\t\tregulations))\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the drug product is compounded using bulk drug\n\t\t\t\tsubstances (as defined in regulations of the "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the bulk drug\n\t\t\t\tsubstances\u2014"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "if an applicable monograph exists under the\n\t\t\t\tUnited States Pharmacopoeia, the National Formulary, or another compendium or\n\t\t\t\tpharmacopeia recognized under Federal law, each comply with the\n\t\t\t\tmonograph;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H9B5EA96762CF4FCA9AC977BFB39B9671", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for human use; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "if such a\n\t\t\t\tmonograph does not exist, each are drug substances that are components of drug\n\t\t\t\tproducts approved or licensed by the "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H928FBA5CC4F843A392B923920DBE0351", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (through regulations issued under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ");", "@entity-type": "act", "#text": "subsection (e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e", "@proposed": "true"}], "#text": "if such a\n\t\t\t\tmonograph does not exist and the drug substance is not a component of a drug\n\t\t\t\tproduct so approved or licensed, each appear on a list published by the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "HDC5598855DB14A1D906FF510B62F5D8C", "#text": "\n                  "}], "#text": "\n                ", "@id": "H05E7E7A1DE0B4D8486A88CE87AFB45BE"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (including a foreign establishment that is registered under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": "); and", "@entity-type": "act", "#text": "section\n\t\t\t\t510(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:i"}], "#text": "the bulk drug\n\t\t\t\tsubstances are each manufactured by an establishment that is registered under\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H0FFDCD2D6CA04709A8C3A55914C142F3", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the bulk drug\n\t\t\t\tsubstances are each accompanied by a valid certificate of analysis."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HD758A1C6E65141E7AFC777BB35B94A4E", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "If any ingredients (other than\n\t\t\t\tbulk drug substances) are used in compounding the drug product, such\n\t\t\t\tingredients comply with the standards of an applicable United States\n\t\t\t\tPharmacopoeia or National Formulary monograph."}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Ingredients\n\t\t\t\t(other than bulk drug substances)"}, "#text": "\n              ", "@id": "H9645846F1B5F4131B9AF800FC3B4ACDD"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " of drug products\n\t\t\t\tthat have been withdrawn or removed from the market because such drug products\n\t\t\t\tor components of such drug products have been found to be unsafe or not\n\t\t\t\teffective.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The drug\n\t\t\t\tproduct does not appear on a list published by the "}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": "\n              ", "#text": "Drug products\n\t\t\t\twithdrawn or removed because unsafe or not effective"}, "#text": "\n              ", "@id": "H1153EA146B86450A98EC03E200D228C2"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The licensed\n\t\t\t\tpharmacist or licensed physician does not compound any drug product that is\n\t\t\t\tessentially a copy of a marketed and approved drug product."}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "header": {"#tail": "\n              ", "#text": "Essentially a\n\t\t\t\tcopy of a marketed and approved drug product"}, "#text": "\n              ", "@id": "HCD9E7F63D954488B9CC5F1563BAC55A7"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (through regulations issued under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ") as a drug product\n\t\t\t\tthat presents demonstrable difficulties for compounding that reasonably\n\t\t\t\tdemonstrate an adverse effect on the safety or effectiveness of that drug\n\t\t\t\tproduct.", "@entity-type": "act", "#text": "subsection (e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e", "@proposed": "true"}], "#text": "The drug product is not identified\n\t\t\t\t(directly or as part of a category of drug products) in a list published by the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(7)"}, "header": {"#tail": "\n              ", "#text": "Drug products\n\t\t\t\tpresenting demonstrable difficulties for compounding"}, "#text": "\n              ", "@id": "H83AC77959E9C4DC9A286D850B2A01EBF"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The drug product\n\t\t\t\twill not be sold by an entity other than the pharmacy or physician that\n\t\t\t\tcompounded such drug product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(8)"}, "header": {"#tail": "\n              ", "#text": "Prohibition on\n\t\t\t\twholesaling"}, "#text": "\n              ", "@id": "H75462EA55CF34E59B0EC9FB2280AD1C1"}], "#text": "\n            ", "@id": "H46C677C3910E4AB68CF037DD7B1EA051"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Nothing in this\n\t\t\t\tsection shall prevent a State from\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "State\n\t\t\t\tregulation"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": " that are in addition to the restrictions applicable under\n\t\t\t\tthis section; or", "@entity-type": "act", "#text": "(C) of\n\t\t\t\tsubsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:C", "@proposed": "true"}], "#text": "imposing\n\t\t\t\trestrictions on the type of compounding described in "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H7E1FF47A82174619A16E68CDF2D7C1D5", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:2", "@proposed": "true"}, "#text": "enforcing\n\t\t\t\trequirements or restrictions contained in the chapters or standards described\n\t\t\t\tin "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H8B60E8F3A8B445C4B59D4F7C2B6AF016", "#text": "\n              "}], "#text": "\n            ", "@id": "H18F948D7CF684AD6947370AA4D58E798", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Notification\n\t\t\t\tsystem"}, "paragraph": [{"#tail": "\n            ", "@id": "HF5C5A7D91D5A4349AE94CFFBA7F30251", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Development and\n\t\t\t\timplementation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall develop and implement a system for receiving and reviewing submissions\n\t\t\t\tfrom State boards of pharmacy\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "describing actions\n\t\t\t\ttaken against compounding pharmacies; or"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H87C2E54CCFC44A0181A8A6012BF6FA98", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "expressing concerns that a com\u00adpound\u00ading\n\t\t\t\tpharmacy may be acting in violation of one or more requirements of this\n\t\t\t\tsection.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H83F523D020294094A5DD4B1FA8608F62", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H5992D3662D8B4F7C953DAF4180709C9E", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Content of\n\t\t\t\tsubmissions from State boards of pharmacy"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is, with respect to a pharmacy that compounds drug\n\t\t\t\tproducts, any of the following:", "@entity-type": "act", "#text": "paragraph (1)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:1/sp:A", "@proposed": "true"}, "#text": "An action referred to\n\t\t\t\tin "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The issuance of a\n\t\t\t\twarning letter, or the imposition of sanctions or penalties, by a State for\n\t\t\t\tviolations of a State\u2019s pharmacy regulations pertaining to compounding."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H7BEBE02548F94DA8BA10909E6C2AC530", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The suspension or\n\t\t\t\trevocation of a State-issued pharmacy license or registration."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HF8B445C43C0E4A5CB16B73AC29743A85", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The recall of\n\t\t\t\tcompounded drug products due to concerns relating to the quality or purity of\n\t\t\t\tsuch products."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HF2F40108DD69446E831A891C332EC7E6", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall develop the system under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in consultation with the\n\t\t\t\tNational Association of Boards of Pharmacy.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:1", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Consultation"}, "#text": "\n              ", "@id": "H2203CB6BB62845A8A626905C08447495"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall review each submission\n\t\t\t\treceived under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and such other information as the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:1", "@proposed": "true"}, {"#tail": "\n\t\t\t\tdetermines necessary (including information collected through an inspection or\n\t\t\t\tmaintained in the Adverse Event Reporting System database) and make a\n\t\t\t\tdetermination as to whether the pharmacy involved may be in violation of one or\n\t\t\t\tmore requirements of this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Review and\n\t\t\t\tdetermination by Secretary"}, "#text": "\n              ", "@id": "H0EA5E4163D0C41D8AADD77D7343BD0B0", "@commented": "no"}, {"#tail": "\n            ", "@id": "H6A581C72E38D49368A3740C9D8B1172E", "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": "\n              ", "#text": "Notifying State\n\t\t\t\tboards of pharmacy"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be designed to immediately notify State boards of\n\t\t\t\tpharmacy when\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:1", "@proposed": "true"}, "#text": "The system\n\t\t\t\tunder ", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\treceives a submission under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "; or", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:1", "@proposed": "true"}], "#text": "the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HA2D734C7712246E5962A9C05B4FA4708", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tmakes a determination that a pharmacy may be in violation of one or more\n\t\t\t\trequirements of this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HA85BAD3ABA694ADD8C3F7D0D711D4F82", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"short-title": {"#tail": ", the ", "#text": "Compounding Clarity Act of\n\t\t\t\t2013"}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall begin implementation of the system\n\t\t\t\tunder ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:1", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t", "#text": "Not\n\t\t\t\tlater than one year after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "header": {"#tail": "\n              ", "#text": "Timing"}, "#text": "\n              ", "@id": "H49E1C6341C084CCE89F830FD9028B3B6"}], "#text": "\n            ", "@id": "H03A230652D6F43FDBDE3B5946739CAFC"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "section 704(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a"}, {"#tail": " may inspect a pharmacy\u2019s records to determine\n\t\t\t\twhether the pharmacy is in violation of one or more requirements of this Act\n\t\t\t\tif\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In accordance with\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n            ", "#text": "Inspection\n\t\t\t\tauthority"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the inspection is conducted in coordination\n\t\t\t\twith the relevant State board or boards of pharmacy; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H8D68E8ACFC044874BDDBCE5BD39CEF4A", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has evidence that the\n\t\t\t\tpharmacy may be in violation of such a requirement.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H112E68E76B15475D8B7BFE16FA3DC30C", "#text": "\n              "}], "#text": "\n            ", "@id": "H0D20C1A48DFE4D409F312F8532046F9A"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Regulations"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall issue regulations to implement this\n\t\t\t\tsection.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "H891E2FDC4D3443D7ABEC494A74FAB293"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)(3)(A)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:iii", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "act", "#text": "(a)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:7", "@proposed": "true"}, {"#tail": " shall convene and consult\n\t\t\t\tan advisory committee on compounding. The advisory committee shall include\n\t\t\t\trepresentatives from the National Association of Boards of Pharmacy, the United\n\t\t\t\tStates Pharmacopoeia, pharmacists having current experience and expertise in\n\t\t\t\tcompounding, physicians having background and knowledge in compounding, and\n\t\t\t\tconsumer organizations with an expertise in compounding.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Before issuing regulations to implement\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Advisory\n\t\t\t\tcommittee on compounding"}, "#text": "\n              ", "@id": "HB309E93E60754F9C96D0910CCFC05EFF"}, {"#tail": "\n            ", "@id": "H308358F736B5497D81DAF5E11950AE6D", "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Interim\n\t\t\t\tlists"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and\n\t\t\t\t", "@entity-type": "act", "#text": "subsections (a)(3)(A)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:iii", "@proposed": "true"}, {"#tail": ", if the ", "@entity-type": "act", "#text": "(a)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:7", "@proposed": "true"}, {"#tail": " determines it is necessary to protect the public\n\t\t\t\thealth, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may designate drug products or substances as described in\n\t\t\t\tsuch subsections, by\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Before the date on\n\t\t\t\twhich final regulations are issued to implement ", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "publishing a notice of such drug products\n\t\t\t\tor substances proposed for designation, including the rationale for such\n\t\t\t\tdesignation, in the Federal Register;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H5D32F2318396422EA3D93D7184EDB393", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "providing a period of not less than 60\n\t\t\t\tcalendar days for comment on the notice; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HA99978F6743742B6A8DEF7B747D396CB", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "publishing a notice in the Federal Register\n\t\t\t\tdesignating such drug products or substances.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HFBDF0B2C1A8746AFBF2ED7A41454C70B", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\tupdate the regulations containing the lists of drug products and substances\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)(3)(A)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:iii", "@proposed": "true"}, {"#tail": " regularly, but not less than\n\t\t\t\tonce every three years.", "@entity-type": "act", "#text": "(a)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:7", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Updating\n\t\t\t\tlists"}, "#text": "\n              ", "@id": "H06FE1960D30C497DA2AB828E2DDC1CA4"}, {"#tail": "\n          ", "@id": "H973B523D73EB46479AAF6251453D787C", "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": "\n              ", "#text": "Sunset of\n\t\t\t\tnotice"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall not be effective after the earlier of\u2014", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3", "@proposed": "true"}, "#text": "Any notice published\n\t\t\t\tunder ", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"short-title": {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Compounding Clarity\n\t\t\t\tAct of 2013", "@value": "Compounding Clarity Act of 2013", "@proposed": "true"}, "#text": "\n                    "}, "#tail": "\n\t\t\t\t\t\t\t", "#text": "the date that is 3\n\t\t\t\tyears after the date of "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HCA24C69E08874E039EFC2AD08DE2DB39", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)(3)(A)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:iii", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(a)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:7", "@proposed": "true"}], "#text": "the effective date of the final regulations\n\t\t\t\tissued to implement ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HF5E2168DC5194D27BD6E56C910BC10A6", "#text": "\n                "}]}], "#text": "\n            ", "@id": "H5FCDC48C095C405EB00F144648104B45"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis section:"}, "enum": {"#tail": "\n            ", "#text": "(f)"}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " includes\u2014", "#text": "compounding"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "H4B8301E3BFB9424FB3535445CEEBEDA2", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the combining, admixing, mixing, diluting,\n\t\t\t\treconstituting, or otherwise altering of a marketed drug product, except when\n\t\t\t\tperformed in accordance with specific directions for such acts contained in\n\t\t\t\tapproved labeling provided by the product\u2019s manufacturer or otherwise provided\n\t\t\t\tby that manufacturer consistent with that labeling;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H2D6876802EFF4E7FA07007C367B65DE6", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the combining, admixing, mixing, diluting,\n\t\t\t\treconstituting, or otherwise altering a bulk drug substance to create a drug\n\t\t\t\tproduct; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H6FCBD59D1C294F698921A8A6A3AEB2D6", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "repackaging.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H09EA848000E9440FB431F8C34248751E", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " does\n\t\t\t\tnot include\u2014", "#text": "essentially a copy of a marketed and approved drug product"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "HED2C144EE1814F62BE983D2C9ECBF7DE", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a drug product in\n\t\t\t\twhich there is a change, made for an identified individual patient, which\n\t\t\t\tproduces for that patient a clinical difference, as determined by the\n\t\t\t\tprescribing practitioner, between the compounded drug product and the\n\t\t\t\tcomparable marketed and approved drug product; or"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H86C85FA5C637436C8917307F71A649FE", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 506E", "@value": "Federal Food, Drug, and Cosmetic Act/s:506E"}, "#text": "a drug product\n\t\t\t\tthat appears on the drug shortage list in effect under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HC6D140E7E6614D3C8F436AABE53B8070", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " includes any individual who compounds drug\n\t\t\t\tproducts under the supervision of a practitioner licensed to compound drug\n\t\t\t\tproducts under State law.", "#text": "licensed pharmacist"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H60A3DCA14EE24AE7A0127100DD543695", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a drug product that\u2014", "#text": "marketed and approved drug\n\t\t\t\tproduct"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "#text": "\n              ", "@id": "HB35D5CC158DD4B9496DB565760F33CBA", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is currently\n\t\t\t\tmarketed; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HD10003C549E146168A233062149A769E", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or licensed under ", "@entity-type": "act", "#text": "section 505 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ".", "@entity-type": "act", "#text": "section 351 of the Public Health\n\t\t\t\tService Act", "@value": "Public Health Service Act/s:351"}], "#text": "is approved under\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H77D47FEAB781464EA646A96FD6C6E23A", "#text": "\n                "}]}, {"#tail": "\n          ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or licensed under ", "@entity-type": "act", "#text": "section 505 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " from the container in which the drug is\n\t\t\t\tdistributed by the original manufacturer and placing such drug in a different\n\t\t\t\tcontainer of the same or smaller size without further manipulating the drug\n\t\t\t\t(such as by diluting it or mixing it with another, different drug or\n\t\t\t\tdrugs).", "@entity-type": "act", "#text": "section\n\t\t\t\t351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "term": {"#tail": " means\n\t\t\t\ttaking a drug approved under ", "#text": "repackaging"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "HDB8A1F13CCEB4D32B473B61A0320D705", "@commented": "no"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Such term does not include removing the\n\t\t\t\tdrug from its original container for immediate administration to an identified\n\t\t\t\tindividual patient, such as withdrawing a drug into a syringe for immediate\n\t\t\t\tinjection or removing the drug from its original container within a health care\n\t\t\t\tentity by a practitioner, or other licensed individual under the supervision or\n\t\t\t\tdirection of such practitioner, for administration within the same day within\n\t\t\t\tsuch health care\n\t\t\t\tentity.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "H1C29372C896B4AFD9E7835C916DE52C4"}], "enum": {"#tail": "\n              ", "#text": "(5)"}, "@id": "H44684B94951C462196412484695A9ECF", "#text": "\n              "}], "#text": "\n            ", "@id": "H2C6742070FE24EC8809C223636A69AB9"}], "#text": "\n          ", "@id": "HF6AD07C0BA4C46B4BA563BA301D43C75"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "HB23B7FC6FB1D48DA9EFFB7148594AD97"}, "#text": "\n      ", "@id": "H50B0465A55DE49C4BA12301EAB9C9236"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Outsourcing\n\t\t\t facilities"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subchapter A of\n\t\t\t chapter V of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as ", "@entity-type": "act", "#text": "section 503B", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B"}, {"#tail": "; and", "@entity-type": "act", "#text": "section 503C", "@value": "Federal Food, Drug, and Cosmetic Act/s:503C", "@proposed": "true"}], "#text": "by redesignating\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HA35F85BD0A1B433586419B917BC01802", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by inserting after\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " the following new section:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 353a", "@value": "usc/21/353a"}, "@parsable-cite": "usc/21/353a", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "section": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "503B."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Outsourcing\n\t\t\t\tfacilities"}, "subsection": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tand ", "@entity-type": "act", "#text": "Sections 502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": " and ", "@entity-type": "act", "#text": "505 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " shall not\n\t\t\t\tapply to a drug product compounded for human use by a licensed pharmacist in an\n\t\t\t\toutsourcing facility if each of the following conditions is met:", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "\n                  ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b", "@proposed": "true"}, "#text": "The facility is in\n\t\t\t\tcompliance with the registration and reporting requirements of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Registration and\n\t\t\t\treporting"}, "#text": "\n                  ", "@id": "H0E8686EE979B49488DBC68443ED57243"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraphs (3) through (8) of section 503A(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3..8", "@proposed": "true"}, "#text": "The facility does not compound drug\n\t\t\t\tproducts in violation of "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Drug product and\n\t\t\t\tsubstance limitations"}, "#text": "\n                  ", "@id": "H7E3D51A8547E4AAF9B82730F9C1DEEE5"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 744K", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K"}, "#text": "The\n\t\t\t\tfacility has paid all fees owed by such facility pursuant to "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Fees"}, "#text": "\n                  ", "@id": "HA7F903E28068481EA44B08C93E7F11AB"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tfacility does not compound, from bulk drug substances, standardized dosages\n\t\t\t\tthat are not otherwise commercially available of a marketed and approved drug\n\t\t\t\tproduct.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Standardized\n\t\t\t\tdrug products from bulk"}, "#text": "\n                  ", "@id": "H452302217B0541058552A32F94707179"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") that prominently identifies the drug as a compounded drug\n\t\t\t\tproduct;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "quote": {"#tail": " or a reasonable comparable alternative statement (as specified by\n\t\t\t\tthe ", "#text": "This is a compounded\n\t\t\t\tdrug."}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the statement ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "H81455AC493424478B786F00B180B3701", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the name, address, and phone number of the\n\t\t\t\tapplicable outsourcing facility; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "H3567FB7664894D9693AF269B74354814", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "with respect to the compounded drug\n\t\t\t\tproduct\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the lot or batch number;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "H7F7B781D50D641E8BB9FF386E069A1D4", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the established name of the drug\n\t\t\t\tproduct;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "H052AD2929A6F4966AD5001734A37EFA7", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the dosage form and strength;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "H6B206D14A3CB4B5992A9658B27DF362C", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the statement of quantity or volume, as\n\t\t\t\tappropriate;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "H4335E6AD87904515B6681DFB81381C74", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the date that the drug product was\n\t\t\t\tcompounded;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(V)"}, "@id": "H07A01B7BB6464CF5936F92A8FA7F3EF3", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the expiration date;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(VI)"}, "@id": "H5837DD540289400D8FE6E094F51A709D", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "storage and handling instructions;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(VII)"}, "@id": "H32A99ABFF72F4A03B6B823C780AE931F", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the National Drug Code number, if\n\t\t\t\tavailable;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(VIII)"}, "@id": "H2BB23753D66A4007B0DEE7C6CE829135", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 503A(a)(1)(C)(v)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:C/cl:v", "@proposed": "true"}, "term": {"#tail": " statement\n\t\t\t\trequired under ", "#text": "Not for resale"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(IX)"}, "@id": "H463B4C528CC747029E1FBB0232689F41", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a list of\n\t\t\t\tactive and inactive ingredients, identified by established name and the\n\t\t\t\tquantity or proportion of each ingredient.", "@entity-type": "act", "#text": "subparagraph (B)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:a/p:5/sp:B/cl:i", "@proposed": "true"}, "#text": "subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                        ", "#text": "(X)"}, "@id": "HEBAB475718F9413DB88E0453B376C4C0", "#text": "\n                        "}], "#text": "\n                      ", "@id": "HD71D0425482D472890567ACB5931C70D"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Label"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The label of a drug product compounded by\n\t\t\t\tan outsourcing facility shall include\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H8B9A7CBFAFC645EEB6C723C5C83D311A"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if there is not space on the label for such\n\t\t\t\tinformation;", "@entity-type": "act", "#text": "subparagraph (A)(iii)(X)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:a/p:5/sp:A/cl:iii/scl:X", "@proposed": "true"}, "#text": "the information described under\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "H3BE02B42F01B491494D515B17EE42624", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the following information to facilitate\n\t\t\t\tadverse event reporting: www.fda.gov/medwatch and 1\u2013800\u2013FDA\u20131088; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "H04EA333154F94665A53EA97566EEB7AC", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "directions for use, including, as\n\t\t\t\tappropriate, dosage and administration.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "H7B3AAE43FBDE4C94BCC9F16F619309BD", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Container"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The container from which the individual\n\t\t\t\tunits of a drug product compounded by an outsourcing facility are removed for\n\t\t\t\tdispensing or for administration (such as a plastic bag containing individual\n\t\t\t\tproduct syringes) shall include\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H313CB63230484A0183DE8C51028DB020"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The label and\n\t\t\t\tlabeling of a drug product compounded by an outsourcing facility shall include\n\t\t\t\tany other information as determined necessary and specified in regulations\n\t\t\t\tpromulgated by the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Additional\n\t\t\t\tinformation"}, "#text": "\n                    ", "@id": "H1D4E6A6AF21848C28077A9FDD08FE237"}], "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Labeling of drug\n\t\t\t\tproducts"}, "#text": "\n                  ", "@id": "H0646FE22A4EE490CB733EDDFAD60665C"}], "#text": "\n                ", "@id": "H08E22E06E53E48B78109340A809F585C"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\toutsourcing facilities and reporting of drug products"}, "paragraph": [{"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " its name, place of business, and unique facility identifier\n\t\t\t\t(which shall conform to the requirements for the unique facility identifier\n\t\t\t\testablished under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "), and a point of contact e-mail address;\n\t\t\t\tand", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "shall register\n\t\t\t\twith the "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "H780306BCEA474518A95CAD23F987770D", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "shall indicate\n\t\t\t\twhether the out\u00adsourc\u00ading facility intends to compound a drug product that\n\t\t\t\tappears on the list in effect under section 506E during the subsequent calendar\n\t\t\t\tyear."}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "H729D51628B2A40B393BD363C668F53E1", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Annual\n\t\t\t\tregistration"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "During the\n\t\t\t\tperiod beginning on October 1 and ending on December 31 each year, each\n\t\t\t\toutsourcing facility\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "HB4F4F0C2BEFF4FA892B48FFE008A08D7"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and provide the information described\n\t\t\t\tin ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". The ", "@entity-type": "act", "#text": "paragraph (1)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b/p:1/sp:A", "@proposed": "true"}, {"#tail": " shall establish a timeline for registration\n\t\t\t\tfor the first calendar year following the effective date of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". In no case may registration be required until at least 60\n\t\t\t\tcalendar days following publication of the timeline in the Federal\n\t\t\t\tRegister.", "@entity-type": "act", "#text": "Compounding\n\t\t\t\tClarity Act of 2013", "@value": "Compounding Clarity Act of 2013", "@proposed": "true"}], "#text": "Each outsourcing\n\t\t\t\tfacility, upon first engaging in compounding pursuant to this section, shall\n\t\t\t\timmediately register with the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "New outsourcing\n\t\t\t\tfacilities"}, "#text": "\n                    ", "@id": "H42887C1EB53F4B2593DF95F350044FDF"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall make available for inspection, to any person so requesting, any\n\t\t\t\tregistration filed pursuant to this paragraph.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Registrations"}, "#text": "\n                      ", "@id": "HCCD356C801E4475F99BDAD05D1A46158"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall make available on the public Internet Web site of the Food and\n\t\t\t\tDrug Administration a list of the name of each facility registered under this\n\t\t\t\tsubsection as an outsourcing facility, the State in which each such facility is\n\t\t\t\tlocated, whether the facility compounds from bulk drug substances, and whether\n\t\t\t\tany such compounding from bulk drug substances is for sterile or non-sterile\n\t\t\t\tdrug products.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "List"}, "#text": "\n                      ", "@id": "H02633FE9762048BFBA2DD440068B6CBE"}], "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Availability of\n\t\t\t\tregistration for inspection; list"}, "#text": "\n                    ", "@id": "H61A6808B429B4FE0861850CB6392561C"}], "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\toutsourcing facilities"}, "#text": "\n                  ", "@id": "HEE60E8E721884A52837C191B6033C15B"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identifying the\n\t\t\t\tdrug products compounded by such outsourcing facility during the previous\n\t\t\t\t6-month period; and"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "H946885D19F8D4938B55519A3E240CADE", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", providing the active ingredient;\n\t\t\t\tthe source of such active ingredient; the National Drug Code number, if\n\t\t\t\tavailable, of the source drug product or bulk active ingredient; the strength\n\t\t\t\tof the active ingredient per unit; the dosage form and route of administration;\n\t\t\t\tthe package description; the number of individual units produced; and the\n\t\t\t\tNational Drug Code number of the final product, if assigned.", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b/p:2/sp:A/cl:i", "@proposed": "true"}, "#text": "with respect to\n\t\t\t\teach drug product identified under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "HF327BDC39D10467E8C09DC60A2E0F6E3", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall submit to\n\t\t\t\tthe ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b/p:1", "@proposed": "true"}, {"#tail": " a report\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon initially\n\t\t\t\tregistering as an outsourcing facility, once during the month of June of each\n\t\t\t\tyear, and once during the month of December of each year, each outsourcing\n\t\t\t\tfacility that registers with the ", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H81AA7FB0351A4F46A97528F6CC49CDB2"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be prepared in such form and manner as the\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b/p:2/sp:A", "@proposed": "true"}, {"#tail": " may prescribe by regulation or guidance.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Each\n\t\t\t\treport under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Form"}, "#text": "\n                    ", "@id": "H772D6EBA0A6A4469B69D023ED8815FBA"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", unless the ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(1)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b/p:1/sp:C", "@proposed": "true"}, {"#tail": " finds that such an exemption would be inconsistent\n\t\t\t\twith the protection of the public health.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Reports\n\t\t\t\tsubmitted under this paragraph shall be exempt from inspection under "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Confidentiality"}, "#text": "\n                    ", "@id": "H731FCDF19F854AEABF171E39B91135D9"}], "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Drug product\n\t\t\t\treporting by outsourcing facilities"}, "#text": "\n                  ", "@id": "H8D17D3ADBB7B41FA8BC993B98A605CDD"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " by electronic means unless the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " grants a request for waiver of such requirement because use of\n\t\t\t\telectronic means is not reasonable for the person requesting waiver.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Registrations and drug product\n\t\t\t\treporting under this subsection (including the submission of updated\n\t\t\t\tinformation) shall be submitted to the "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Electronic\n\t\t\t\tregistration and reporting"}, "#text": "\n                  ", "@id": "HDD292B52B3BD45369238DA4000C362EF"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, "#text": "shall be subject\n\t\t\t\tto inspection pursuant to "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "HF75AF74698FD4A919DB771B27047F556", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 704(a)(2)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a/p:2/sp:A"}, "#text": "shall not be\n\t\t\t\teligible for the exemption under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "H47D3E1F88E92452B96EF5B9356B040E1", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Outsourcing facilities\u2014"}, "#text": "\n                    ", "@id": "HDE65618E71FA437B9BBD692B13AD6EFE"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through one or more officers or\n\t\t\t\temployees duly designated by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall inspect outsourcing\n\t\t\t\tfacilities in accordance with a risk-based schedule established by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Risk-based\n\t\t\t\tschedule"}, "#text": "\n                    ", "@id": "H0C68477737BB4E398935B8E1EEA5A6B4"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The compliance\n\t\t\t\thistory of the outsourcing facility."}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "H4246C8FC7C2E4515A8D15571F7023662", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The record,\n\t\t\t\thistory, and nature of recalls linked to the outsourcing facility."}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "H7E49B224033C4EDCB0B2F0D3254410FE", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The inherent\n\t\t\t\trisk of the drug products compounded at the outsourcing facility."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "H7ABAC6A832844E29A19AE48EC250E6AE", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The inspection\n\t\t\t\tfrequency and history of the outsourcing facility, including whether the\n\t\t\t\toutsourcing facility has been inspected pursuant to section 704 within the last\n\t\t\t\t4 years."}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "@id": "HDB81A87DCF6F43758E34694F8CC45817", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 506E", "@value": "Federal Food, Drug, and Cosmetic Act/s:506E"}, "#text": "Whether the\n\t\t\t\toutsourcing facility has registered under this paragraph as an entity that\n\t\t\t\tintends to compound a drug product that appears on the list in effect under\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(v)"}, "@id": "HAE1D8EBF6EF34898BE4FF55BEC4D9D34", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for purposes of\n\t\t\t\tallocating inspection resources.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Any other\n\t\t\t\tcriteria deemed necessary and appropriate by the "}, "enum": {"#tail": "\n                      ", "#text": "(vi)"}, "@id": "HDF44104A149444588ECF34EA4DE2195A", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Risk\n\t\t\t\tfactors"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall inspect outsourcing facilities according to the known safety risks of\n\t\t\t\tsuch outsourcing facilities, which shall be based on the following\n\t\t\t\tfactors:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In establishing the risk-based schedule, the "}, "#text": "\n                    ", "@id": "HA2BBFBFF1BAB40F1841D1A64CBEEF3B0"}], "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Risk-based\n\t\t\t\tinspection frequency"}, "#text": "\n                  ", "@id": "HFA5CC7BB996A41A399E7D939D1C3DBB3"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tin accordance with the content and format requirements established through\n\t\t\t\tguidance or regulation under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Outsourcing\n\t\t\t\tfacilities shall be required to submit adverse event reports to the ", "external-xref": [{"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulations) or ", "@parsable-cite": "usc/21/310", "#text": "section 310.305", "@legal-doc": "usc"}, {"#tail": " of title 21, Code\n\t\t\t\tof Federal Regulations (or any successor regulations).", "@parsable-cite": "usc/21/600", "#text": "section 600.80", "@legal-doc": "usc"}], "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n                  ", "#text": "Adverse event\n\t\t\t\treporting"}, "#text": "\n                  ", "@id": "HE2695A95F47B4523B665D5DD565D0DBA"}], "#text": "\n                ", "@id": "H1BEB0849D7D344D19F8C8EBDB8FF4CAE"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis section:"}, "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n                ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 503A(a)(1)(C)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1/sp:C/cl:iii", "@proposed": "true"}, "term": {"#tail": " means a facility at one geographic location\n\t\t\t\tor address that compounds sterile drug products for office use in excess of the\n\t\t\t\tlimitation set forth in ", "#text": "outsourcing facility"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Outsourcing\n\t\t\t\tfacility"}, "#text": "\n                  ", "@id": "HDDEF64A872F54904B0B0498772E1EB54"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 503A(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:f", "@proposed": "true"}, "term": [{"#tail": ", ", "#text": "compounding"}, {"#tail": ", ", "#text": "essentially\n\t\t\t\ta copy of a marketed and approved drug product"}, {"#tail": ", and ", "#text": "licensed\n\t\t\t\tpharmacist"}, {"#tail": " have the\n\t\t\t\tmeanings given such terms in ", "#text": "marketed and approved drug product"}], "#text": "The terms "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Other\n\t\t\t\tdefinitions"}, "#text": "\n                  ", "@id": "H1C7CFE62E783448AB58C8588FF20D950"}], "#text": "\n                ", "@id": "H428494251FFA41A1A0F8B1F9885B464A"}], "#text": "\n              ", "@id": "H982C2E77027943C286D40C3C02DDA2CE"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "HF8CB560F5B4E447A8C3193E91E025410"}, "#text": "\n          ", "@id": "H87E8085C6697455BA438B89765447EB3"}], "#text": "\n        ", "@id": "H3E3EF7E5C5FB4AF18D544A4880116067"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at\n\t\t\t the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subchapter C of chapter VII of the Federal\n\t\t\t Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379f et seq.", "@value": "usc/21/379f/etseq"}, "@parsable-cite": "usc/21/379f", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Fees"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "part": {"#tail": "\n          ", "section": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In this part:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n              ", "#text": "744J."}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " has the meaning given such term in ", "#text": "affiliate"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "HFFF42BE8CAD9404DBF37791BB54D0B13", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the total worldwide gross annual sales,\n\t\t\t\tin United States dollars, for an outsourcing facility, including the sales of\n\t\t\t\tall the affiliates of the outsourcing facility.", "#text": "gross annual sales"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "H1C75E8830C0B4003B29EA44BE610191A", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t503B(c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:c", "@proposed": "true"}, "term": {"#tail": " has the meaning given to such term in ", "#text": "outsourcing facility"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "@id": "H09C57C29FBCF4B7885B8F5AB59579F71", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " subsequent to an inspection\n\t\t\t\tconducted under such provision which identified noncompliance materially\n\t\t\t\trelated to an applicable requirement of this Act, specifically to determine\n\t\t\t\twhether compliance has been achieved to the ", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, {"#tail": " satisfaction.", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}], "term": {"#tail": " means, with respect to an outsourcing facility, one\n\t\t\t\tor more inspections conducted under ", "#text": "reinspection"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "@id": "H44D97FB755234E7B92629EDDD6EA3460", "#text": "\n                "}], "#text": "\n              ", "@id": "HF6CADABF342B48FD85BB37D48FE34399"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "744K."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Authority to\n\t\t\t\tassess and use outsourcing facility fees"}, "subsection": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "\u2014"}, "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n                ", "#text": "Establishment\n\t\t\t\tand reinspection fees"}, "paragraph": [{"#tail": "\n                ", "@id": "H3F561692B28641F2A3CC2BFF93F050C8", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall, in accordance with this subsection, assess and collect\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "For fiscal year 2015 and each subsequent fiscal year, the\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "an annual\n\t\t\t\testablishment fee from each outsourcing facility; and"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "HA79E6BB626714683948C5EF7A79A8FB4", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a reinspection fee\n\t\t\t\tfrom each outsourcing facility subject to a reinspection in such fiscal\n\t\t\t\tyear."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "H8F46CB403FE24B0189D4B952129F20FC", "#text": "\n                    "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "An outsourcing facility subject to multiple\n\t\t\t\treinspections in a fiscal year shall be subject to a reinspection fee for each\n\t\t\t\treinspection."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Multiple\n\t\t\t\treinspections"}, "#text": "\n                  ", "@id": "HA0F18EEF86EA4E1684F32D2C5AD58E17"}], "#text": "\n                ", "@id": "H51ACD15A551F47689867AF796A56138A"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n                ", "#text": "Establishment\n\t\t\t\tand reinspection fee setting"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c", "@proposed": "true"}, "#text": "establish the\n\t\t\t\tamount of the establishment and reinspection fee to be collected under this\n\t\t\t\tsection for each fiscal year based on the methodology described in "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@id": "HD8F85BB127904DF8B67A8EE23517C80E", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish such fee\n\t\t\t\tamounts in a Federal Register notice not later than 60 calendar days before the\n\t\t\t\tstart of each such year."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "HCBD33B785F9F43AF9E2F995110AE83B4", "#text": "\n                  "}], "#text": "\n                ", "@id": "HFB79A726B198448AA5C7C7A376EF68CD"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Amount of\n\t\t\t\testablishment fee and reinspection fee"}, "paragraph": [{"#tail": "\n                ", "@id": "H9CB96C7D429C45D4979181EB62ED941F", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "For each outsourcing facility in a fiscal year\u2014"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the amount of the annual establishment fee under ", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:4", "@proposed": "true"}, {"#tail": " shall be equal to the sum of\u2014", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:b", "@proposed": "true"}], "#text": "except as provided\n\t\t\t\tin "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t\tplus", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:2", "@proposed": "true"}, "#text": "$15,000,\n\t\t\t\tmultiplied by the inflation adjustment factor described in "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "HCAC9A060F11F433E9A13ED0B55F99236", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:3", "@proposed": "true"}, "#text": "the small\n\t\t\t\tbusiness adjustment factor described in "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "HF15519671EB24ACABDDA23AA29557240", "#text": "\n                      "}], "#text": "\n                    ", "@id": "H5363C70CB39F4E7781CD34020E654659"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be equal to\n\t\t\t\t$15,000, multiplied by the inflation adjustment factor described in ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:3", "@proposed": "true"}], "#text": "the amount of any\n\t\t\t\treinspection fee (if applicable) under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "H3F927571B2CD4A5BA955A25365952A4D", "#text": "\n                    "}]}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "one;"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "H46C0EECC2B5946D1B9C883E850BF2164", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", of all personnel compensation and benefits paid\n\t\t\t\twith respect to such positions for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears, multiplied by the proportion of personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " for the first 3 years of the preceding 4 fiscal years;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}], "#text": "the average\n\t\t\t\tannual percent change in the cost, per full-time equivalent position of the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "HCA09A524E4F94190B34A82EA6EB8180C", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears.", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}, "#text": "the average\n\t\t\t\tannual percent change that occurred in the Consumer Price Index for urban\n\t\t\t\tconsumers (U.S. City Average; Not Seasonally Adjusted; All items; Annual Index)\n\t\t\t\tfor the first 3 years of the preceding 4 years of available data multiplied by\n\t\t\t\tthe proportion of all costs other than personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the "}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "H002ED734CFB54D15BE1DC60C753634B8", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be adjusted by the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:1", "@proposed": "true"}, {"#tail": " by\n\t\t\t\tnotice, published in the Federal Register, for a fiscal year by the amount\n\t\t\t\tequal to the sum of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years, the fee\n\t\t\t\tamounts established in "}, "#text": "\n                    ", "@id": "HA9ED69CBC4E94DA3A909C77708521A43"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall be added on a compounded basis to the sum of all adjustments made each\n\t\t\t\tfiscal year after fiscal year 2014 under ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:2/sp:A", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:2/sp:A", "@proposed": "true"}], "#text": "The adjustment made each fiscal year under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Compounded\n\t\t\t\tbasis"}, "#text": "\n                    ", "@id": "HAAF61DDC243548B3B552A6673D34C60B"}], "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Inflation\n\t\t\t\tadjustment factor"}, "#text": "\n                  ", "@id": "H8E16EFC487EE4E04920F99CC3D8F239C"}, {"#tail": "\n                ", "@id": "H76739D4813424D28BFD296C443D98EC9", "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Small business\n\t\t\t\tadjustment factor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be an amount established by the ", "@entity-type": "act", "#text": "paragraph (1)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " for\n\t\t\t\teach fiscal year based on the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " estimate of\u2014", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}], "#text": "The small business adjustment factor referred\n\t\t\t\tto in "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tsmall businesses that will pay a reduced establishment fee for such fiscal\n\t\t\t\tyear; and"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "H12B3EC8101F8434D9E1EB4327C32E0F3", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " would have collected if no entity qualified for the small\n\t\t\t\tbusiness exception in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:4", "@proposed": "true"}], "#text": "the adjustment to\n\t\t\t\tthe establishment fee necessary to achieve total fees equaling the total fees\n\t\t\t\tthat the "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "HA892F6CAA0B6411BBB3CAC70274C717E", "#text": "\n                    "}]}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal\n\t\t\t\tyear shall be equal to ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:b", "@proposed": "true"}, {"#tail": " for such fiscal year.", "@entity-type": "act", "#text": "paragraph (1)(A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:1/sp:A/cl:i", "@proposed": "true"}], "#text": "In the case of an outsourcing facility with gross annual\n\t\t\t\tsales of $1,000,000 or less in the 12 months ending April 1 of the fiscal year\n\t\t\t\timmediately preceding the fiscal year in which the fees under this section are\n\t\t\t\tassessed, the amount of the establishment fee under ", "fraction": {"#tail": " of the amount calculated under\n\t\t\t\t", "#text": "1/3"}}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "HB80FAF3A39A34951974B3DAD7EB6F8AE"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " a written request for such exception, in a format specified by\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in guidance, certifying its gross annual sales for the 12 months\n\t\t\t\tending April 1 of the fiscal year immediately preceding the fiscal year in\n\t\t\t\twhich fees under this subsection are assessed. Any such application shall be\n\t\t\t\tsubmitted to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not later than April 30 of such immediately\n\t\t\t\tpreceding fiscal year.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To\n\t\t\t\tqualify for the exception under this paragraph, a small business shall submit\n\t\t\t\tto the "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Application"}, "#text": "\n                    ", "@id": "H239EBFEFF2C84F89A4593DD95C5FEAD1"}], "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exception for\n\t\t\t\tsmall businesses"}, "#text": "\n                  ", "@id": "H21B74FCDA1BB4E51AC3E7F9DD251AB05"}, {"#tail": "\n              ", "@id": "H50E8D04F6A0A44A182A4D94E685F6185", "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n                  ", "#text": "Crediting of\n\t\t\t\tfees"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year, the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:c/p:3", "@proposed": "true"}, {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In establishing the small business adjustment factor under\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\toverestimated the amount of the small business adjustment factor for such\n\t\t\t\tprevious fiscal year; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "provide for the\n\t\t\t\tcrediting of fees from the previous year to the next year if the "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "HA564DA3200C44CBCBFEB89778DA786DF", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tdetermines appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "consider the need\n\t\t\t\tto account for any adjustment of fees and such other factors as the "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "H69252CFD2D1848D8A3B4ABA30063C1D6", "#text": "\n                    "}]}], "#text": "\n                ", "@id": "H4C14EA23FA9D49D1A9DCECE8586F81AE"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make all of the fees collected pursuant\n\t\t\t\tto ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subparagraphs (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:a/p:1/sp:A", "@proposed": "true"}, {"#tail": " available solely to pay for\n\t\t\t\tthe costs of oversight of outsourcing facilities.", "@entity-type": "act", "#text": "(B) of subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n                ", "#text": "Use of\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "H43303A6C94C24009882E6D058B87D59C"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " pursuant to this section\n\t\t\t\tshall be used to supplement and not supplant any other Federal funds available\n\t\t\t\tto carry out the activities described in this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Funds received by the "}, "enum": {"#tail": "\n                ", "#text": "(e)"}, "header": {"#tail": "\n                ", "#text": "Supplement not\n\t\t\t\tsupplant"}, "#text": "\n                ", "@id": "H6D50C0863EDB4FBA84E6CDFA5013CF24"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " salaries and expenses appropriation account\n\t\t\t\twithout fiscal year limitation to such appropriation account for salaries and\n\t\t\t\texpenses with such fiscal year limitation. The sums transferred shall be\n\t\t\t\tavailable solely for the purpose of paying the costs of oversight of\n\t\t\t\toutsourcing facilities.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Fees authorized under this section shall be\n\t\t\t\tcollected and available for obligation only to the extent and in the amount\n\t\t\t\tprovided in advance in appropriations Acts. Such fees are authorized to remain\n\t\t\t\tavailable until expended. Such sums as may be necessary may be transferred from\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(f)"}, "header": {"#tail": "\n                ", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "#text": "\n                ", "@id": "HA16CF21777FC41E08620B49BEB3CC5E4"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collection of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such fiscal year.", "@entity-type": "act", "#text": "section 503B(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b", "@proposed": "true"}, "#text": "An outsourcing facility shall remit the establishment fee due\n\t\t\t\tunder this section in a fiscal year when submitting a registration pursuant to\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Establishment\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "HB3259CE825F84029BB349994C84E69E3"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall specify in the Federal Register notice\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the manner in which reinspection fees assessed\n\t\t\t\tunder this section shall be collected and the timeline for payment of such\n\t\t\t\tfees. Such a fee shall be collected after the ", "@entity-type": "act", "#text": "subsection (b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K/ss:b/p:2", "@proposed": "true"}, {"#tail": " has conducted a\n\t\t\t\treinspection of the outsourcing facility involved.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Reinspection\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "HC606E6F9DA034BBEA2FE34962A43E71B"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tin a fiscal year until the date that the outsourcing facility remits the\n\t\t\t\testablishment fee under this subsection for such fiscal year.", "@entity-type": "act", "#text": "section 503B(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b", "@proposed": "true"}, "#text": "An\n\t\t\t\toutsourcing facility shall not be considered registered under "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Registration"}, "#text": "\n                    ", "@id": "H42997030E26F4262A35A912C72877A4A"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " until the fees owed for such outsourcing facility under this\n\t\t\t\tsection have been paid.", "@entity-type": "act", "#text": "section 502", "@value": "Federal Food, Drug, and Cosmetic Act/s:502"}, "#text": "All\n\t\t\t\tdrug products manufactured, prepared, propagated, compounded, or processed by\n\t\t\t\tan outsourcing facility for which any establishment fee or reinspection fee has\n\t\t\t\tnot been paid, as required by this section, shall be deemed misbranded under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Misbranding"}, "#text": "\n                    ", "@id": "H85E315EC490D4C279CF5FCC8C100E33A"}], "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Effect of\n\t\t\t\tfailure to pay fees"}, "#text": "\n                  ", "@id": "HC5034754CEDD4762A6A960B8E6AFD92B"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive\n\t\t\t\tpayment of a fee assessed under this section within 30 calendar days after it\n\t\t\t\tis due, such fee shall be treated as a claim of the United States Government\n\t\t\t\tsubject to provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States\n\t\t\t\tCode", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Collection of\n\t\t\t\tunpaid fees"}, "#text": "\n                  ", "@id": "H71EBCDA4CB2D4539BE52EA44214DE9DC"}], "#text": "\n                ", "@id": "H6D67D120A2BC40BEA35D5CFB2F9BA641"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall submit a report to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor, and\n\t\t\t\tPensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": ", to include a description of fees assessed and collected for\n\t\t\t\tsuch year, a summary description of entities paying the fees, a description of\n\t\t\t\tthe hiring and placement of new staff, a description of the use of fee\n\t\t\t\tresources to support inspecting outsourcing facilities, and the number of\n\t\t\t\tinspections and reinspections of such facilities performed each year.", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the House of\n\t\t\t\tRepresentatives", "@entity-id": "HIF00"}], "#text": "Not later than 120 calendar days after each fiscal year\n\t\t\t\tin which fees are assessed and collected under this section, the "}, "enum": {"#tail": "\n                ", "#text": "(h)"}, "header": {"#tail": "\n                ", "#text": "Annual report to\n\t\t\t\tCongress"}, "#text": "\n                ", "@id": "H39A7D9A6CFE14F4C9EF2B7D6C295E1A5"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "\n                  ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n                ", "@entity-type": "auth-auth-approp", "#text": "\n                    ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ", there is authorized to be appropriated ", "#text": "For fiscal year 2015 and each subsequent fiscal\n\t\t\t\tyear", "@amount": "indefinite", "@year": "2015,.."}, "{http://namespaces.cato.org/catoxml}property": {"#tail": " an\n\t\t\t\tamount equivalent to the total amount of fees assessed for such fiscal year\n\t\t\t\tunder this section.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "this subsection", "@value": "Federal Food, Drug, and Cosmetic Act/s:744K", "@proposed": "true"}, "#text": "for fees under ", "@name": "purpose"}}}, "enum": {"#tail": "\n                ", "#text": "(i)"}, "header": {"#tail": "\n                ", "#text": "Authorization of\n\t\t\t\tappropriations"}, "#text": "\n                ", "@id": "H44AC35543B1844AC9DBFFE17FE666FA2"}], "#text": "\n              ", "@id": "HAEBDFFFCDA8844A7B2C60C40CB65842E"}], "enum": {"#tail": "\n            ", "#text": "9"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Fees\n\t\t\t\trelating to outsourcing facilities"}, "#text": "\n            ", "@id": "H68E9D3DCC9124856AA05316E8E567727"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H9A00E29E83E24B68AF6EA1D4E9AB19FF"}, "#text": "\n        ", "@id": "H6ACE05EA5B064FE2996D346BB7AD90B2"}], "#text": "\n      ", "@id": "H0703424917A147D0B18F91703825BBEC"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Prohibited\n\t\t\t acts"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the\n\t\t\t following:", "@entity-type": "act", "#text": "paragraph (bbb)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/p:bbb"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 301 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:301"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 331", "@value": "usc/21/331"}, "@parsable-cite": "usc/21/331", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Intentional\n\t\t\t falsification of prescription order for compounded drug product"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}, {"#tail": ", the intentional falsification of a\n\t\t\t\tprescription, a purchase order, or patient name required under ", "@entity-type": "act", "#text": "503B", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B", "@proposed": "true"}, {"#tail": " or\n\t\t\t\t", "@entity-type": "act", "#text": "section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "503B", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B", "@proposed": "true"}], "#text": "With respect to a drug product to be\n\t\t\t\tcompounded under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(ccc)"}, "@id": "HBE6D26231EB1402EB870EF282A5EA4DE", "#text": "\n            "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H408062BD546943C5828CDF2CC9F99E79"}, "#text": "\n        ", "@id": "HCA8D845EC38C451EA5A121A411C647F9"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", is further amended\n\t\t\t by inserting after ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Compounding Clarity Act of 2013/s:4/ss:a", "@proposed": "true"}, {"#tail": " (as added by such subsection), the\n\t\t\t following:", "@entity-type": "act", "#text": "paragraph (ccc)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/p:ccc"}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as amended by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 301 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:301"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 331", "@value": "usc/21/331"}, "@parsable-cite": "usc/21/331", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Intentional\n\t\t\t failure of outsourcing facility To register"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", the intentional failure of the outsourcing facility to so\n\t\t\t\tregister.", "@entity-type": "act", "#text": "section\n\t\t\t\t503B(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503B/ss:b", "@proposed": "true"}], "#text": "With respect to any year in which an\n\t\t\t\toutsourcing facility is required to register with the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(ddd)"}, "@id": "HFD4449B7BBA14102B3862EAF55B57562", "#text": "\n            "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H5C022E641B484583AE5B6B37C77E834B"}, "#text": "\n        ", "@id": "H5F742B84FEEE414FAFBC57F3C695DF2B"}], "#text": "\n      ", "@id": "H5AF6F55F64DC45DD9E725EC2CBFE1A6E"}], "#text": "\n\t\t", "@id": "H31A33BDC72FB461BB49B80E808A81040"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-09-12"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 3089 IH: Compounding Clarity Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}